Display options
Cite
Correction: TRAIL and Doxorubicin Combination Induces Proapoptotic and Antiangiogenic Effects in Soft Tissue Sarcoma In Vivo. Clin Cancer Res. 2015;21(7):1773doi: 10.1158/1078-0432.CCR-15-0301.
(2015). Correction: TRAIL and Doxorubicin Combination Induces Proapoptotic and Antiangiogenic Effects in Soft Tissue Sarcoma In Vivo. Clinical cancer research : an official journal of the American Association for Cancer Research, 21(7), 1773. https://doi.org/10.1158/1078-0432.CCR-15-0301
"Correction: TRAIL and Doxorubicin Combination Induces Proapoptotic and Antiangiogenic Effects in Soft Tissue Sarcoma In Vivo." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 21,7 (2015): 1773. doi: https://doi.org/10.1158/1078-0432.CCR-15-0301
Correction: TRAIL and Doxorubicin Combination Induces Proapoptotic and Antiangiogenic Effects in Soft Tissue Sarcoma In Vivo. Clin Cancer Res. 2015 Apr 01;21(7):1773. doi: 10.1158/1078-0432.CCR-15-0301. PMID: 25833310.
Copy Download .nbib Format: NLM
Share it on

Clin Cancer Res. 2015 Apr 01;21(7):1773. doi: 10.1158/1078-0432.CCR-15-0301.

Correction: TRAIL and Doxorubicin Combination Induces Proapoptotic and Antiangiogenic Effects in Soft Tissue Sarcoma In Vivo.

Clinical cancer research : an official journal of the American Association for Cancer Research

[No authors listed]

PMID: 25833310 DOI: 10.1158/1078-0432.CCR-15-0301

[No abstract available.]

Publication Types